These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 12839933)
1. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938 [TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
4. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Joseph IB; Isaacs JT Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270 [TBL] [Abstract][Full Text] [Related]
7. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers. Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342 [TBL] [Abstract][Full Text] [Related]
8. [Upregulation of vascular endothelial growth factor by peroxide in human colon cancer]. Zhu J; Yu B; Ji Y; Zheng M; Li D Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):271-4. PubMed ID: 11953178 [TBL] [Abstract][Full Text] [Related]
9. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515 [TBL] [Abstract][Full Text] [Related]
11. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Bobrovnikova-Marjon EV; Marjon PL; Barbash O; Vander Jagt DL; Abcouwer SF Cancer Res; 2004 Jul; 64(14):4858-69. PubMed ID: 15256456 [TBL] [Abstract][Full Text] [Related]
12. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo. Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202 [TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation. Jongsma J; Oomen MH; Noordzij MA; Van Weerden WM; Martens GJ; van der Kwast TH; Schröder FH; van Steenbrugge GJ Cancer Res; 2000 Feb; 60(3):741-8. PubMed ID: 10676662 [TBL] [Abstract][Full Text] [Related]
17. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8. Harada K; Supriatno ; Yoshida H; Sato M Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203 [TBL] [Abstract][Full Text] [Related]
18. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor. Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]